Strategy Asset Managers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.32M Sell
35,910
-534
-1% -$61.6K 0.71% 42
2025
Q4
$3.84M Buy
36,444
+3,676
+11% +$345K 0.63% 42
2025
Q3
$2.75M Sell
32,768
-553
-2% -$45.5K 0.49% 49
2025
Q2
$2.64M Buy
33,321
+795
+2% +$63.2K 0.49% 51
2025
Q1
$2.92M Sell
32,526
-1,587
-5% -$148K 0.6% 47
2024
Q4
$3.39M Sell
34,113
-1,892
-5% -$195K 0.66% 45
2024
Q3
$4.09M Sell
36,005
-12,053
-25% -$1.43M 0.78% 39
2024
Q2
$5.55M Buy
48,058
+11,957
+33% +$1.54M 1.23% 29
2024
Q1
$4.76M Sell
36,101
-4,830
-12% -$595K 1.02% 36
2023
Q4
$4.46M Sell
40,931
-897
-2% -$93.1K 1.06% 34
2023
Q3
$4.31M Sell
41,828
-6,230
-13% -$671K 1.13% 29
2023
Q2
$5.55M Buy
48,058
+5,305
+12% +$602K 1.23% 29
2023
Q1
$4.55M Buy
42,753
+3,776
+10% +$408K 1.11% 32
2022
Q4
$4.33M Sell
38,977
-220
-0.6% -$22.5K 1.1% 31
2022
Q3
$3.38M Buy
39,197
+8,209
+26% +$733K 0.92% 37
2022
Q2
$2.83M Buy
30,988
+673
+2% +$59.7K 0.87% 34
2022
Q1
$2.49M Buy
30,315
+2,961
+11% +$233K 0.54% 52
2021
Q4
$2.1M Sell
27,354
-3,147
-10% -$251K 0.54% 47
2021
Q3
$2.29M Sell
30,501
-465
-2% -$35.4K 0.51% 51
2021
Q2
$2.41M Sell
30,966
-88,114
-74% -$6.55M 0.51% 48
2021
Q1
$8.76M Sell
119,080
-3,694
-3% -$272K 2.01% 13
2020
Q4
$9.58M Sell
122,774
-4,652
-4% -$356K 2.29% 9
2020
Q3
$10.1M Sell
127,426
-15,117
-11% -$1.18M 2.62% 4
2020
Q2
$10.5M Sell
142,543
-3,899
-3% -$294K 2.82% 5
2020
Q1
$10.8M Sell
146,442
-10,154
-6% -$798K 3.46% 4
2019
Q4
$13.6M Sell
156,596
-1,813
-1% -$149K 3.35% 3
2019
Q3
$12.7M Buy
158,409
+3,137
+2% +$251K 3.79% 4
2019
Q2
$12.4M Buy
155,272
+167
+0.1% +$12.8K 3.52% 4
2019
Q1
$12.3M Buy
155,105
+7,823
+5% +$585K 2.77% 4
2018
Q4
$10.7M Sell
147,282
-7,748
-5% -$547K 2.62% 6
2018
Q3
$10.5M Sell
155,030
-2,851
-2% -$182K 2.13% 12
2018
Q2
$9.14M Sell
157,881
-2,873
-2% -$162K 1.93% 20
2018
Q1
$8.36M Sell
160,754
-4,050
-2% -$219K 1.81% 22
2017
Q4
$8.85M Buy
164,804
+992
+0.6% +$55K 1.73% 23
2017
Q3
$10M Sell
163,812
-2,350
-1% -$142K 2.05% 19
2017
Q2
$10.2M Sell
166,162
-7,267
-4% -$442K 2.09% 18
2017
Q1
$10.5M Sell
173,429
-4,075
-2% -$247K 2.28% 12
2016
Q4
$10.4M Sell
177,504
-3,824
-2% -$224K 2.28% 12
2016
Q3
$10.8M Sell
181,328
-2,756
-1% -$161K 2.42% 4
2016
Q2
$10.1M Sell
184,084
-3,044
-2% -$162K 2.3% 8
2016
Q1
$9.45M Buy
187,128
+2,294
+1% +$112K 2.15% 12
2015
Q4
$9.32M Sell
184,834
-6,230
-3% -$314K 2.12% 15
2015
Q3
$9M Sell
191,064
-1,144
-0.6% -$60.8K 2.16% 16
2015
Q2
$10.4M Sell
192,208
-902
-0.5% -$50.6K 2.33% 12
2015
Q1
$10.6M Sell
193,110
-3,537
-2% -$200K 2.31% 9
2014
Q4
$10.7M Sell
196,647
-1,412
-0.7% -$78.7K 2.24% 14
2014
Q3
$11.2M Buy
198,059
+1,258
+0.6% +$70.6K 2.45% 9
2014
Q2
$10.9M Sell
196,801
-3,960
-2% -$216K 2.31% 12
2014
Q1
$10.9M Sell
200,761
-2,150
-1% -$111K 2.34% 13
2013
Q4
$9.69M Buy
202,911
+5,905
+3% +$270K 2.12% 15
2013
Q3
$8.95M Sell
197,006
-887
-0.4% -$40.5K 2.11% 14
2013
Q2
$8.77M Buy
+197,893
New +$8.84M 2.09% 13

Other funds holding MRK

Strategy Asset Managers's MRK Position: Q1 2026 in Review

Strategy Asset Managers reduced its Merck (MRK) stake by 1.5% in Q1 2026, selling an estimated $61.6K and leaving 35,910 shares worth $4.32M. The position accounts for 0.71% of the portfolio, ranked #42.

Strategy Asset Managers first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.6M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Strategy Asset Managers held 35,910 shares of Merck worth $4.32M as of Q1 2026.
  • Strategy Asset Managers sold 534 Merck shares in Q1 2026, an estimated $61.6K.
  • Merck made up 0.71% of Strategy Asset Managers's portfolio in Q1 2026, its #42 holding.
  • Strategy Asset Managers first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Strategy Asset Managers's Merck position peaked at $13.6M in Q4 2019.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.